🇪🇺 Columvi in European Union

EMA authorised Columvi on 7 July 2023

Marketing authorisation

EMA — authorised 7 July 2023

  • Marketing authorisation holder: ROCHE REGISTRATION GMBH
  • Status: approved

Columvi in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Columvi approved in European Union?

Yes. EMA authorised it on 7 July 2023.

Who is the marketing authorisation holder for Columvi in European Union?

ROCHE REGISTRATION GMBH holds the EU marketing authorisation.